Stocksigma LogoStocksigma Logo

Transgene Biotek Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 6.0 (+13.6% YoY | +0.0% QoQ) ■ EBITDA: -1.5 (+80.5% YoY | +75.1% QoQ) ■ EBITDA Margin (%): -24.2 (+11655 bps YoY | +7283 bps QoQ) ■ PAT: -34.5

Transgene Biotek Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Transgene Biotek Ltd · Financial Result · 13 Nov 2026, 6:53 pm

Transgene Biotek Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 6.0 (+13.6% YoY | +0.0% QoQ) ■ EBITDA: -1.5 (+80.5% YoY | +75.1% QoQ) ■ EBITDA Margin (%): -24.2 (+11655 bps YoY | +7283 bps QoQ) ■ PAT: -34.5 (+11.1% YoY | +11.2% QoQ) ■ EPS (INR): -0.05 (+0.0% YoY | +0.0% QoQ)

Original exchange filing (PDF)

More announcements from Transgene Biotek Ltd

All Transgene Biotek Ltd announcements